Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution

References

• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
   PubMed Web of Science ®Google Scholar
• Talbot K. Motor neuron disease: the bare essentials. Practical Neurol. 2009;9:303–9.
   PubMedGoogle Scholar
• del Aguila MA, Longstreth WT, Jr., McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813–19.
   PubMed Web of Science ®Google Scholar
• Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983;68:20–9.
   PubMed Web of Science ®Google Scholar
• Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–9.
   PubMed Web of Science ®Google Scholar
• Ince PG, Codd GA. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathol Appl Neurobiol. 2005;31:345–53.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Therrien M, Dion PA, Rouleau GA. ALS: recent developments from genetics studies. Curr Neurol Neurosci Rep. 2016;16:59.
   PubMed Web of Science ®Google Scholar
• Huisman MH, Seelen M, de Jong SW, Dorresteijn KR, van Doormaal PT, van der Kooi AJ, et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:976–81.
   PubMed Web of Science ®Google Scholar
• Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C, Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016;31:7–19.
   PubMed Web of Science ®Google Scholar
• Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R, et al. ALS: a bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol. 2016;142:104–29.
   PubMed Web of Science ®Google Scholar
• Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11:439–42.
   PubMed Web of Science ®Google Scholar
• Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:208–12.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210–21.
   PubMed Web of Science ®Google Scholar
• Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology. 1997;48:55–7.
   PubMed Web of Science ®Google Scholar
• Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
   PubMed Web of Science ®Google Scholar
• Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, et al. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany–completeness of the ALS registry Swabia. PLoS One. 2014;9:e93932.
   PubMed Web of Science ®Google Scholar
• Piemonte, Valle d'Aosta Register for Amyotrophic Lateral S. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
   PubMed Web of Science ®Google Scholar
• Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448–55.
   PubMed Web of Science ®Google Scholar
• Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci. 1994;122:148–54.
   PubMed Web of Science ®Google Scholar
• Neilson S, Gunnarsson LG, Robinson I. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand. 1994;90:150–9.
   PubMed Web of Science ®Google Scholar
• Veiga-Cabo J, Almazan-Isla J, Sendra-Gutierrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol. 1997;26:1024–32.
   PubMed Web of Science ®Google Scholar
• Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.
   PubMed Web of Science ®Google Scholar
• Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand. 2001;104:232–5.
   PubMed Web of Science ®Google Scholar
• Govoni V, Granieri E, Fallica E, Casetta I. Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964-1998. J Neurol. 2005;252:1322–7.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005;25:144–52.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol. 2005;15:20–3.
   PubMed Web of Science ®Google Scholar
• Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
   PubMed Web of Science ®Google Scholar
• Cima V, Logroscino G, D'Ascenzo C, Palmieri A, Volpe M, Briani C, et al. Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol. 2009;16:920--4.
   PubMed Web of Science ®Google Scholar
• Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:515–19.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemp Degener. 2014;15:262–8.
   PubMed Web of Science ®Google Scholar
• Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007;22:781–90.
   PubMed Web of Science ®Google Scholar
• ARPA (Regional Agency for the Protection of the Environment). Approfondimento delle attività di analisi e di studio sulla contaminazione diffusa del suolo e delle acque sotterranee di alcune aree della Provincia di Novara; 2010.
   Google Scholar
• Rabellotti R, Il distretto della Rubinetteria del Piemonte Nord Orientale. In: Baici E, ed. L’economia novarese Analisi delle caratteristiche e prospettive del sistema economico provinciale. Novara: Interlinea; 2003.
   Google Scholar
• Rogatti C. Il distretto dei rubinetti: la strategia delle imprese del settore della rubinetteria. Il caso CARLO NOBILI S.p.A. Novara: Università degli Studi del Piemonte Orientale 'Amedeo Avogadro'; 2013.
   Google Scholar
• DGR 22-12378 26 aprile 2004. Istituzione e modalita’ di attivazione dell’anagrafe regionale dei siti da bonificare a seguito dei criteri generali definiti dalla L.R. 42/2000. Suppl BU n 21 del 27 maggio 2004; 2004.
   Google Scholar
• DLgs 152/2006. Norme in materia ambientale. GU n 88 del 14 aprile 2006; 2006.
   Google Scholar
• DLgs 31/2001. Attuazione della direttiva 98/83/CE relativa alla qualità delle acque destinate al consumo umano. GU n52 del 3-3-2001-Suppl Ordinario n 41; 2001.
   Google Scholar
• Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Migliaretti G, Berchialla P, Dalmasso P, Cavallo F, Chio A. Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases. Amyotroph Lateral Scler Frontotemp Degener. 2013;14:58–65.
   PubMed Web of Science ®Google Scholar
• Bandettini di Poggio M, Sormani MP, Truffelli R, Mandich P, Origone P, Verdiani S, et al. Clinical epidemiology of ALS in Liguria, Italy. Amyotroph Lateral Scler Frontotemp Degener. 2013;14:52–7.
   PubMed Web of Science ®Google Scholar
• Bonvicini F, Vinceti M, Marcello N, Rodolfi R, Rinaldi M. The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler. 2008;9:350–3.
   PubMed Web of Science ®Google Scholar
• Bocca B, Forte G, Oggiano R, Clemente S, Asara Y, Peruzzu A, et al. Level of neurotoxic metals in amyotrophic lateral sclerosis: a population-based case-control study. J Neurol Sci. 2015;359:11–17.
   PubMed Web of Science ®Google Scholar
• Malek AM, Barchowsky A, Bowser R, Heiman-Patterson T, Lacomis D, Rana S, et al. Exposure to hazardous air pollutants and the risk of amyotrophic lateral sclerosis. Environ Pollut. 2015;197:181–6.
   PubMed Web of Science ®Google Scholar
• Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:803–11.
   PubMed Web of Science ®Google Scholar
• Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2016. [Epub ahead of print]. doi: 10.1016/j.neuro.2016.06.015.
   Google Scholar
• Rooney J, Vajda A, Heverin M, Crampsie A, Tobin K, McLaughlin R, et al. No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland. Environ Res. 2016;147:102–7.
   PubMed Web of Science ®Google Scholar
• Vinceti M, Bottecchi I, Fan A, Finkelstein Y, Mandrioli J. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? Rev Environ Health. 2012;27:19–41.
   PubMedGoogle Scholar
• Capozzella A, Sacco C, Chighine A, Loreti B, Scala B, Casale T, et al. Work related etiology of amyotrophic lateral sclerosis (ALS): a meta-analysis. Ann Ig. 2014;26:456–72.
   PubMedGoogle Scholar